Trial Profile
Phase I/II trial of GX 301 in patients with prostate cancer or renal cancer
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 04 Dec 2012
Price :
$35
*
At a glance
- Drugs GX 301 (Primary)
- Indications Prostate cancer; Renal cancer
- Focus Adverse reactions; Therapeutic Use
- 04 Dec 2012 New trial record
- 01 Feb 2012 Status changed from recruiting to completed.
- 01 Oct 2011 The prostate cancer cohort of the trial was completed in October 2011. Recruitment was ongoing in the renal cancer cohort